THOMMEN MEDICAL AG
Manufacturer adverse-event records for THOMMEN MEDICAL AG come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2018–2026 · mid-book · quiet Death-code · injury-heavy
Injury-mix signature
THOMMEN MEDICAL AG leans injury-heavy in event_type mix
Injury-coded event_type share is 100.0% (injury-heavy tercile) beside 0.00% Death-coded (quiet). Volume band: mid.
What the Injury-mix reading shows for THOMMEN MEDICAL AG
The standout signal for THOMMEN MEDICAL AG is Injury-mix: 100.0% Injury-coded (injury-heavy) beside 0.00% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for THOMMEN MEDICAL AG. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 2 device types, led in this extract by Injury at 21,033 (100.0% of event_type total). Peak single-year volume reaches 3,604 reports across 9 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (2)
| Device | Reports |
|---|---|
| Implant, Endosseous, Root-Form | 21,038 |
| Capsule, Dental, Amalgam | 1 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.